Bo Lan

BRCAness ‐Driven Prognostic Model and Regimen‐Specific Therapeutic Implications in Triple‐Negative Breast Cancer With Residual Disease After Neoadjuvant Chemotherapy

BRCAness, a phenotype associated with homologous recombination deficiency, has not been fully characterized in triple-negative breast cancer (TNBC) with residual disease after neoadjuvant chemotherapy (NAC), especially regarding prognosis and regimen-specific postoperative manage...